290 related articles for article (PubMed ID: 26999376)
1. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.
Shenoy S; Thompson AA
Ann N Y Acad Sci; 2016 Mar; 1368(1):122-6. PubMed ID: 26999376
[TBL] [Abstract][Full Text] [Related]
2. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
Fitzhugh CD; Abraham A; Hsieh MM
Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
[TBL] [Abstract][Full Text] [Related]
3. Rapid and complete donor chimerism after unrelated mismatched cord blood transplantation in 5 children with beta-thalassemia major.
Jaing TH; Hung IJ; Yang CP; Chen SH; Sun CF; Chow R
Biol Blood Marrow Transplant; 2005 May; 11(5):349-53. PubMed ID: 15846288
[TBL] [Abstract][Full Text] [Related]
4. Thalassemia Major: Transplantation or Transfusion and Chelation.
Mohamed SY
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
[TBL] [Abstract][Full Text] [Related]
5. Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.
Shenoy S; Walters MC; Ngwube A; Soni S; Jacobsohn D; Chaudhury S; Grimley M; Chan K; Haight A; Kasow KA; Parikh S; Andreansky M; Connelly J; Delgado D; Godder K; Hale G; Nieder M; Pulsipher MA; Trachtenberg F; Neufeld E; Kwiatkowski JL; Thompson AA
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1216-1222. PubMed ID: 29374585
[TBL] [Abstract][Full Text] [Related]
6. Matched sibling donor hematopoietic stem cell transplantation for thalassemia.
Issaragrisil S; Kunacheewa C
Curr Opin Hematol; 2016 Nov; 23(6):508-514. PubMed ID: 27518930
[TBL] [Abstract][Full Text] [Related]
7. Umbilical cord blood transplantation in Chinese children with beta-thalassemia.
Fang J; Huang S; Chen C; Zhou D; Li CK; Li Y; Huang K
J Pediatr Hematol Oncol; 2004 Mar; 26(3):185-9. PubMed ID: 15125611
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic/Matched Related Transplantation for β-Thalassemia and Sickle Cell Anemia.
Bernaudin F; Pondarré C; Galambrun C; Thuret I
Adv Exp Med Biol; 2017; 1013():89-122. PubMed ID: 29127678
[TBL] [Abstract][Full Text] [Related]
9. Is the Benefit-Risk Ratio for Patients with Transfusion-Dependent Thalassemia Treated by Unrelated Cord Blood Transplantation Favorable?
Jaing TH
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156642
[TBL] [Abstract][Full Text] [Related]
10. Successful unrelated umbilical cord blood transplantation for class 3 β-thalassemia major using a reduced-toxicity regimen.
Soni S; Breslin N; Cheerva A
Pediatr Transplant; 2014 Mar; 18(2):E41-3. PubMed ID: 24330091
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic Stem Cell Transplantation in Thalassemia.
Algeri M; Lodi M; Locatelli F
Hematol Oncol Clin North Am; 2023 Apr; 37(2):413-432. PubMed ID: 36907612
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin.
Kothari A; Ngwube A; Hayashi R; Murray L; Davis J; Haut P; Loechelt BJ; Shenoy S
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1321-5. PubMed ID: 25840334
[TBL] [Abstract][Full Text] [Related]
13. Transplantation for thalassemia major: alternative donors.
Locatelli F; Merli P; Strocchio L
Curr Opin Hematol; 2016 Nov; 23(6):515-523. PubMed ID: 27537474
[TBL] [Abstract][Full Text] [Related]
14. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.
Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A
J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518
[TBL] [Abstract][Full Text] [Related]
17. [Combined transplantation of umbilical cord blood and bone marrow from same sibling donor in children with beta-thalassemia major].
Sun X; Hao WG; Liu S; Xia T; Li Y; Liao C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):801-4. PubMed ID: 17708807
[TBL] [Abstract][Full Text] [Related]
18. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
[TBL] [Abstract][Full Text] [Related]
19. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT.
Savani BN; Labopin M; Kröger N; Finke J; Ehninger G; Niederwieser D; Schwerdtfeger R; Bunjes D; Glass B; Socié G; Ljungman P; Craddock C; Baron F; Ciceri F; Gorin NC; Esteve J; Schmid C; Giebel S; Mohty M; Nagler A
Haematologica; 2016 Jun; 101(6):773-80. PubMed ID: 26969081
[TBL] [Abstract][Full Text] [Related]
20. The Saudi experience in fludarabine-based conditioning regimens in patients with Fanconi anemia undergoing stem cell transplantation: excellent outcome in recipients of matched related stem cells but not in recipients of unrelated cord blood stem cells.
Ayas M; Al-Seraihi A; El-Solh H; Al-Ahmari A; Khairy A; Aldali A; Markiz S; Siddiqui K; Al-Jefri A
Biol Blood Marrow Transplant; 2012 Apr; 18(4):627-32. PubMed ID: 21871862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]